Essential medicines and health products

Multimedia: Videos

Animation: School of INN

The School of INN is a WHO International Nonproprietary Name Programme initiative. Its role would be to educate the pharmaceutical industry on how to design and construct an INN, and to provide information to healthcare professionals on how to interpret an INN.

Animation: Access to Medicines

What does it take to become a good medicine? Understand the different implications and stakeholders in producing and releasing a medicine on the market. The WHO Essential Medicines and Health Products (EMP) Department works with countries to promote affordable access to quality, safe and effective medicines, vaccines, diagnostics and other medical devices.

Vietnam

Vietnam and access to health products

Vietnam is a country whose government has started an ambitious journey towards providing all of its citizens with reliable and accessible health care. In spite of the many challenges, the Vietnamese government has been making impressive progress. “Our charge is to take care of the health of the Vietnamese population - 92 million people,” Dr. Luong Ngoc Khue. “We are very proud of what we have achieved but there are still a lot of challenges that need to be met.”

Supply & demand of medicines and vaccines in Vietnam

The Vietnamese Government has an ambitious goal, to produce 90% of the essential medicines its people need by 2020. The effort is considered positive for the economy as well as necessary for the nation’s health. “Being self-sufficient is a very big achievement for Vietnam, it shows a scientific development pathway for Vietnam when you compare us to other countries, especially other developing countries.”- Dr. Nguyen.

Tanzania

Pioneering methadone programme gives hope to thousands in Dar es Salaam

In a discreet corner of the Mwananyamala District Hospital grounds, in Dar es Salaam, a group of young people queue up outside a small window to get their daily fix of methadone. “We are among the first and the most successful methadone programmes on the continent”, Dr Pilly says proudly.

Cancer in Tanzania

Cancer is on the rise in developing countries, where about 70% of all cancer deaths occur. Tanzania is no exception, with about 21 000 reported deaths from cancer in 2014 and 35 000 new cases each year. In spite of the emergence of cancer as a serious public health issue, the country has only two cancer hospitals, the main one situated in the capital, Dar es Salaam. Late diagnosis and shortages of chemotherapy drugs and morphine make cancer treatment difficult. WHO is helping to improve cancer prevention, early diagnosis and treatment services so that more lives can be saved.

Access to Medicines in Tanzania

In recent years Tanzania has made considerable progress in access to quality essential medicines and health products. Despite progress, more work remains to address public health challenges regarding frequent stockouts, lack of access to medical equipment, and substandard and counterfeit medicines. With support from WHO, Tanzania is working to achieve affordable access to quality medicines and health technologies for the whole population.

Ethiopia

Renewed Partnership - Ethiopia

The Ethiopian segment of the Renewed Partnership has focused on the implementation of medicines policies and drug regulations, and the adoption of best practices. It is designed to promote a stronger pharmaceutical sector to increase access to quality medicines. “We are united in the overarching goal of improving the availability, affordability and use of safe, effective and quality essential medicines for priority communicable and non-communicable diseases for all Ethiopians.” - Kebede Worku, MD, MPH, State Minister of Health, Federal Democratic Republic of Ethiopia

Mali

Les médicaments essentiels au Mali – l’âme du système sanitaire

Les médicaments essentiels au Mali – l’âme du système sanitaire.
Bien que les problèmes de santé soient nombreux, le Mali a fait des progrès constants dans l'augmentation de l'accès aux médicaments essentiels au cours des dernières années, en grande partie grâce aux efforts déployés par le Gouvernement, et par l’OMS à travers un projet financé par l’Union Européenne. Mais le Mali continue à être confronté à plusieurs défis en matière d’accès aux médicaments de qualité.